PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PARP1 inhibition affects pleural mesothelioma cell viability and uncouples AKT/mTOR axis via SIRT1
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume 17, Issue 2, Pages 233-241
Publisher
Wiley
Online
2013-01-11
DOI
10.1111/jcmm.12000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BGP-15, a PARP-inhibitor, prevents imatinib-induced cardiotoxicity by activating Akt and suppressing JNK and p38 MAP kinases
- (2012) Zsolt Sarszegi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The role of PARP1 in the DNA damage response and its application in tumor therapy
- (2012) Zhifeng Wang et al. Frontiers of Medicine
- A One and a Two … Expanding Roles for Poly(ADP-Ribose) Polymerases in Metabolism
- (2011) Xin Luo et al. Cell Metabolism
- PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
- (2011) Péter Bai et al. Cell Metabolism
- Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance
- (2011) Rui-Hong Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- BRCA1 is an essential mediator of vinorelbine-induced apoptosis in mesothelioma
- (2011) Sara Busacca et al. JOURNAL OF PATHOLOGY
- Asbestos exposure affects poly(ADP-ribose) polymerase-1 activity: role in asbestos-induced carcinogenesis
- (2011) M. Tomasetti et al. MUTAGENESIS
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- The Deacetylase SIRT1 Promotes Membrane Localization and Activation of Akt and PDK1 During Tumorigenesis and Cardiac Hypertrophy
- (2011) N. R. Sundaresan et al. Science Signaling
- Update on Malignant Pleural Mesothelioma
- (2011) Nicholas Campbell et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: Result in a cohort of 203 resection specimens
- (2010) Aneil A. Mujoomdar et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
- (2010) Hiyaa Singhee Ghosh et al. PLoS One
- Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation
- (2010) Haining Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol
- (2009) Arpad Szanto et al. BIOCHEMICAL PHARMACOLOGY
- Malignant Pleural Mesothelioma
- (2009) Mandira Ray et al. CHEST
- mTOR Mediates Survival Signals in Malignant Mesothelioma Grown as Tumor Fragment Spheroids
- (2008) Shannon M. Wilson et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Mammalian Target of Rapamycin Contributes to the Acquired Apoptotic Resistance of Human Mesothelioma Multicellular Spheroids
- (2008) Dario Barbone et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases
- (2008) M NERI et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
- (2008) S. Rottenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started